NOVACUTAN
LIVE

Serial Number

79379230

Owner

Laboratoires Fijie

Attorney

Amanda M. Prose

Filing Date

Jul 5, 2023

Add to watchlist:

No watchlists yet
View on USPTO

NOVACUTAN Trademark

Serial Number: 79379230 • Registration: 7772575

NOVACUTAN is a trademark filed by Laboratoires Fijie on July 5, 2023. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Laboratoires Fijie

91 rue de Monceau

Entity Type: 34

Trademark Details

Filing Date

July 5, 2023

Registration Date

April 29, 2025

Published for Opposition

March 11, 2025

Goods & Services

Research and development of new products, for others; biological research; scientific research services in the field of cosmetology

Medical services; cosmetology services, including beautician services and artist make-up services; hygienic care services for individuals; hairdressing services; manicure services; massage; advisory services in the field of cosmetic body and beauty care; advisory services concerning medical services; consultation with respect to pharmacy

cosmetic products, namely beauty creams, gels, lotions, and masks, cosmetic powders, body emulsions, beauty serums, shampoos, hair conditioners, bath foams, and body sprays; cosmetic products based on hyaluronic acid, namely beauty creams, gels, lotions, and masks, cosmetic powders, body emulsions, beauty serums, shampoos, hair conditioners, bath foams, and body sprays; cosmetic products based on hyaluronic acid for hypodermic injections

medical products, including based on hyaluronic acid, namely dermal fillers, gel filler; implants, including surgical and medical implants, including those made from materials that are artificial, intradermal, intradermal based on hyaluronic acid or hyaluronic-acid-based materials, namely implants comprising natural, non-living materials; cannulae; surgical and medical apparatus and instruments, namely injection needles with round end points with lateral eyes; implantable devices, namely implantable drug delivery ports for the subcutaneous release of medicated substances; syringes for medical use; syringes for injections; hypodermic syringes

pharmaceutical preparations based on Botulinum toxin type A-hemagglutinin complex for treatment of blepharospasm and chronic migraine and for use in cosmetic medicine; pharmaceutical preparations based on hyaluronic acid, namely for hypodermic injections, for treatment of arthrosis and for use in ophtalmic surgery; biological preparations for medical use for the treatment of blepharospasm and chronic migraine and for use in cosmetic medicine; biological preparations for medical use for the treatment of arthrosis and for use in ophtalmic surgery; vitamin preparations; mineral supplements; albuminous multivitamin preparations for medical use

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 5, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 14, 2025 FICS
FINAL DISPOSITION PROCESSED
Nov 14, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 29, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 29, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 29, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 11, 2025 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 8, 2025 OPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 20, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 20, 2025 OPNR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 12, 2025 CNSA
ASSIGNED TO EXAMINER
Feb 7, 2025 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 2, 2024 TROA
REFUSAL PROCESSED BY IB
Apr 30, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 5, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 5, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 19, 2024 RFCR
NON-FINAL ACTION WRITTEN
Mar 18, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 18, 2024 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Nov 24, 2023 NREP
APPLICATION FILING RECEIPT MAILED
Sep 26, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 22, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 21, 2023 REPR